About Us

ReCyte Therapeutics, Inc. is a regenerative medicine company focused on repair of vascular disorders, including both age-related diseases and injuries. The company was founded in January 2011 as a subsidiary of BioTime, Inc. with a significant investment by private shareholders and by BioTime. Our therapeutic products are derived from human stem cells in vitro, including from embryonic and induced pluripotent stem cell sources. In composition, these therapeutics are designed to be either cellular or totally acellular for specific uses, the latter representing an entirely new class of stem cell-derived therapeutics.